4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)

The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of t...

Full description

Saved in:
Bibliographic Details
Main Authors Zhong, Min, Kim, Jae, Aubele, Danielle, Mcdowell, Robert, Oslob, Johan, Sran, Arvinder, Song, Yonghong
Format Patent
LanguageEnglish
Published 24.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.
AbstractList The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.
Author Song, Yonghong
Aubele, Danielle
Kim, Jae
Zhong, Min
Sran, Arvinder
Oslob, Johan
Mcdowell, Robert
Author_xml – fullname: Zhong, Min
– fullname: Kim, Jae
– fullname: Aubele, Danielle
– fullname: Mcdowell, Robert
– fullname: Oslob, Johan
– fullname: Sran, Arvinder
– fullname: Song, Yonghong
BookMark eNqFjLsKAjEQRVNo4esXZEotFsRdsBZRrKysbJaYTNhAMhOSSbF_7wr2VhcO59ylmhETLtTQNRFlGEOpwTGNoSn1XcRLFbSQfMLsrSeEmlGD4Zi4ki3gOIMMCDJhiUgC7MD6oL-Z0dl6jiMnPV3Dzpq4X6u506Hg5rcrtb1dn5d7g4l7LEkbJJT-8Tq13eF4OLd_hQ9pL0G6
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID NZ734020A
GroupedDBID EVB
ID FETCH-epo_espacenet_NZ734020A3
IEDL.DBID EVB
IngestDate Fri Nov 01 05:35:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NZ734020A3
Notes Application Number: NZ20160734020
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231124&DB=EPODOC&CC=NZ&NR=734020A
ParticipantIDs epo_espacenet_NZ734020A
PublicationCentury 2000
PublicationDate 20231124
PublicationDateYYYYMMDD 2023-11-24
PublicationDate_xml – month: 11
  year: 2023
  text: 20231124
  day: 24
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies MYOKARDIA INC
RelatedCompanies_xml – name: MYOKARDIA INC
Score 3.5029116
Snippet The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM)...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231124&DB=EPODOC&locale=&CC=NZ&NR=734020A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1NS8NAEB1qFfWm9fuj7EGCHoIl3STmEMQmLUUwLVKl9FKym40W2qSYFOm_dyZNqxdvyy5ZNgMv8yb7ZgbgJsagQdkUqSrL1Ll0TF0YkaUbqqEiR4ShXKktAqv7xp-H5rACH-tcmKJO6HdRHBERJRHvefG9nv_-xPILbWV2LyY4lT52Bq6vldExkhX0V5rfctv9nt_zNM9zg5EWvLp2kwKlpy3YRg5tExTa7y1KSZn_9SedA9jp41ZJfggVldRgz1u3XavB7kt5243DEnjZEXxynXo9L6fZYhqTmFzPEPGra_6IzSdUrxi9kGIkMmekE6d2SRlDSsqQ4rGNnpylMYsm05Aek4UWdbZMqS3xkt1GcnZ3DPVOe-B1dTzyeGOccTAqX615AtUkTdQZMGQRVixj24yNBo-k4YQ8fFBNhwthmiKU53D6zyYX_65cwj7Zl9LwDH4F1fxroa7RH-eiXtjyB7lmlCs
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1NT8JAEJ0gGvGm-P2BezCNHhpJ2bb20BhpIahQiEFDuJDudqsk0BJbYvj3zpaCXrhtdtPNdpLXedN9MwNwE2LQIEwZqQpDVym3dJVpgaFqoioCi_k-X6otPKP1Tl8G-qAAn6tcmKxO6E9WHBERxRHvafa9nv39xHIzbWVyz8Y4FT82-7ar5NExkhX0V4pbtxu9rtt1FMexvaHivdlmTQZKT1uwjfzalFBofNRlSsrsvz9p7sNOD7eK0gMoiKgMJWfVdq0Mu538thuHOfCSQ_iiquz1vJgk80koxeRqgohfXvMHZDaW9YrRCwkiReZE6sRlu6SEICUlSPHIWk9O4pAE44kvH-OZFnW6iGVb4gW5Dfj07ggqzUbfaal45NHaOCNvmL9a7RiKURyJUyDIIoyQh6YealUacM3yqf8gahZlTNeZz8_gZMMm5xtXrqHU6nfao_az93oBe9LWMiVPo5dQTL_n4gp9c8oqmV1_AdkZlx4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4-methylsulfonyl-substituted+piperidine+urea+compounds+for+the+treatment+of+dilated+cardiomyopathy+%28dcm%29&rft.inventor=Zhong%2C+Min&rft.inventor=Kim%2C+Jae&rft.inventor=Aubele%2C+Danielle&rft.inventor=Mcdowell%2C+Robert&rft.inventor=Oslob%2C+Johan&rft.inventor=Sran%2C+Arvinder&rft.inventor=Song%2C+Yonghong&rft.date=2023-11-24&rft.externalDBID=A&rft.externalDocID=NZ734020A